Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Response to Arguments
Applicant’s amendment filed 10/15/2026 incorporated into independent claims chemical structure of hydrotalcite which overcomes the teachings of Ichiyanagi. Applicants also amended content of the lithium salt such that content of the salt is either equal to the amount of nucleating agent or higher (up to and including 400) which also overcomes teachings of Fukunaga. The amendment overall obviated rejections of record.
Updated search did provide a reference that is applicable to at least independent claims. Consequently, this office action is final as necessitated by amendment. Currently pending claims are 1, 5, 7-11.
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
Claim Rejections - 35 USC § 103
The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action.
Claims 1, 5, 7-11are rejected under 35 U.S.C. 103 as being unpatentable over Cui (WO 2016/158258) wherein US 2018/0072931 is used as translation.
With respect to claims 1 and 7, Cui teaches additive to a thermoplastic resin composition comprising:
Aromatic metal phosphate of formula 3 or 4 (Abstract):
PNG
media_image1.png
260
280
media_image1.png
Greyscale
PNG
media_image2.png
246
420
media_image2.png
Greyscale
Wherein R1-R4 are alkyls having 1-9 carbon atoms. Examples of more specific embodiments are shown in [0140] of Cui.
Salt of hydroxy substituted fatty acid [0144] having 1-40 carbon atoms and following structure:
PNG
media_image3.png
114
328
media_image3.png
Greyscale
Wherein n is 1-4 and the most preferred embodiment for M is lithium [0149].
Hydrotalcite having following structure [0230-0232]. :
PNG
media_image4.png
132
516
media_image4.png
Greyscale
The structure of the hydrotalcite is exactly the same as the structure of the instant invention.
With respect to the amounts of the components, according to claims 1 and 2 of Cui teaches:
nucleator (phosphate compound) is in a range of 0.001-50 parts
fatty acid salt is in a range of 10-50 parts
Based on the end points of the ranges the content of the fatty acid salt (lithium salt) is 1:1 which meets requirements of instant claim 1. Utilizing examples in Table 1 as a guidance to better understand the content of the two compounds, Examples 1-1 to 1-6 utilize mixture of fatty acid salts and nucleating agent. In the examples combination of nucleating agents are utilized in amount of 0.1, 0.15, 0.2 and 0.25. Combination of fatty acid salts is in 0.55 for all examples. In all examples content of fatty acid salt is utilized in excess. Normalizing content of nucleating agent to 100, the content of the salt can be 100 based on the disclosed ranges and based on the example 1-1, the content is approximately 300, examples 1-2 to 1-4 is approximately 200, examples 1-5 and 1-6 are more than 400 therefore outside of the claimed content.
While hydrotalcite, disclosed as complex salt [0230] is not exemplified, it is clearly envisaged by Cui and its amount is 0.001-5 parts but reported based on the amount of 100 parts of resin.
Cui discloses that the content of nucleating agent based and fatty acid salt on the amount resin is 0.001-50 parts and 10-50 parts respectively [0021, 0025]. Amount of hydrotalcite based on the lower end of the nucleating agent can be 100 parts.
In the light of the above disclosure it would have been obvious to one having ordinary skill in the art at the time instant invention was filed to utilize hydrotalcite as disclosed above. Such modification would be obvious because hydrotalcite are known to have many functions. As double layered hydroxide with high surface area, hydrotalcite can neutralize acid via anionic exchange which improves thermal stability of the polymer. Hydrotalcites are also known as flame retardants and halogen scavengers (if used.
With respect to claim 5, most preferred salts of Cui are lithium myristate, lithium stearate and lithium 12-hydroxystearate [0149].
With respect to claims 8-11, the matrix polymers of Cui include polyolefins such as polypropylene homopolymer [0153]. See also claim 20. Polypropylene is also exemplified. The additive is melt blended with polypropylene.
Conclusion
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Correspondence
Any inquiry concerning this communication or earlier communications from the examiner should be directed to KATARZYNA I KOLB whose telephone number is (571)272-1127. The examiner can normally be reached M-F.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mark Eashoo can be reached at 5712701046. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/KATARZYNA I KOLB/Primary Examiner, Art Unit 1767 November 5, 2026